Fraud Repression believes that “information on the composition and good use practices” are essential for “preventing the risk of toxic shock syndrome”, a rare but potentially fatal disease.
:quality(50)/2023/07/06/64a68815cd1a7_placeholder-36b69ec8.png)
Published
Update
Reading time: 1 min
:quality(50)/2024/03/08/080-hl-jffort-1463113-65eb2cf96a28d503525688.jpg)
Each year, some 2.8 billion sanitary protection products are sold in France. Manufacturers of these feminine intimate protection products will have to detail their composition on the packaging or instructions for use from April 1, announced the Directorate General for Competition, Consumer Affairs and Fraud Control (DGCCRF) on Friday 8 March. Will thus be mentioned, for each of these products, “the details of the substances and materials incorporated”, “the mention of the terms and precautions of use”, as well as “possible adverse effects (irritation, intolerance, allergies, micro-trauma) or more serious ones such as menstrual toxic shock syndrome (TSS)”.
Fraud Repression specifies that a woman “uses between 6 000 and 13 000 disposable intimate protection products during its lifetime” and “information on the composition and good practices for use” are essential for “prevention of the risk of toxic shock syndrome”. This syndrome, the occurrence of which is estimated by Inserm at around a hundred cases per year, is “mainly caused by the use of internal periodic protection, namely tampons and menstrual cups”further details the DGCCRF.
The decree which comes into force on April 1 was published at the end of December in the Official Journal. However, the text provides “an authorized period for the sale of stocks already placed on the market until December 31”specifies the DGCCRF.
